ITYAX
Price
$84.69
Change
+$2.34 (+2.84%)
Updated
Jun 2 closing price
Net Assets
3.02B
SCMIX
Price
$301.49
Change
-$2.87 (-0.94%)
Updated
Jun 3 closing price
Net Assets
29.78B
Interact to see
Advertisement

ITYAX vs SCMIX

Header iconITYAX vs SCMIX Comparison
Open Charts ITYAX vs SCMIXBanner chart's image
ITYAX vs SCMIX Comparison Chart in %
View a ticker or compare two or three
VS
ITYAX vs. SCMIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITYAX is a Buy and SCMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SCMIX has more cash in the bank: 29.8B vs. ITYAX (3.02B). ITYAX (0.00) and SCMIX (0.00) have matching dividends . ITYAX was incepted earlier than SCMIX: ITYAX (24 years) vs SCMIX (25 years). ITYAX (1.02) is less costly to investors than SCMIX (0.87). ITYAX is a more actively managed with annual turnover of: 134.00 vs. SCMIX (33.00). SCMIX has a lower initial minimum investment than ITYAX: SCMIX (0) vs ITYAX (1000). SCMIX annual gain was more profitable for investors over the last year : 110.97 vs. ITYAX (38.77). SCMIX return over 5 years is better than : 116.58 vs. ITYAX (19.32).
ITYAXSCMIXITYAX / SCMIX
Total Expense Ratio1.020.87117%
Annual Report Gross Expense Ratio1.020.87117%
Fund Existence24 years25 years-
Gain YTD45.49058.83577%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.02B29.8B10%
Annual Yield % from dividends0.000.00-
Returns for 1 year38.77110.9735%
Returns for 3 years85.72157.5854%
Returns for 5 years19.32116.5817%
Returns for 10 years143.57403.8236%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRICX26.43N/A
N/A
MFS Research International C
NEOYX33.08N/A
N/A
Natixis Oakmark Y
GGEFX23.58N/A
N/A
Summitry Equity Fund
TIOPX18.31N/A
N/A
Nuveen International Opps Prem
BRUGX17.64N/A
N/A
MFS Blended Research Value Equity C